Dr. Gustavo Henrique Oliveira da Rocha

Profile

Academic positionLecturer, Assistant Professor, Researcher
Research fieldsPharmacology,Immunology
KeywordsBiomarkers, AhR ligands, Inflammatory bowel disease, Preclinical drug development, PPARg
Honours and awards

2016: Best Master's Work, International Symposium on Pathophysiology and Toxicology, University of São Paulo, Brazil

2014: Best Undergraduate Work, Winter School of Toxicology, University of São Paulo, Brazil

2013: Science Without Borders Research Internship Award, University of Ottawa, Canada

Current contact address

CountryBrazil
CitySão Paulo
InstitutionUniversidade de Sao Paulo (USP)
InstituteFaculdade de Ciências Farmacêuticas

Host during sponsorship

Dr. Jörg LehmannAbteilung Präklinische Entwicklung und Validierung, Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Leipzig
Prof. Sandra Helena Poliselli FarskyFaculdade de Ciências Farmacêuticas, Universidade de Sao Paulo (USP), São Paulo
Start of initial sponsorship01/07/2023

Programme(s)

2022CAPES-Humboldt Research Fellowship Programme for Postdocs

Publications (partial selection)

2025Janine Haupt, Oliver Keminer, Christina Neser, Björn Windshügel, Vivien Wiltzsch, Johannes R. Schmidt, Palina Pliushcheuskaya, Georg Künze, Ulrike Scholz, Claudia Müller, Gustavo Henrique Oliveira da Rocha, Melina K. Biermann, Daniela Zdzieblo, Marco Metzger, Ingolf Schiefke, Markus F. Neurath, Britta Siegmund, Carsten Claussen, Ulrike Köhl, Gerd Geisslinger, Mirko Buchholz, Stefan Kalkhof, Jörg Lehmann: Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing. In: Biochemical Pharmacology, 240, 2025,
2024Gustavo Henrique Oliveira da Rocha, Claudia Müller, Susanne Przybylski-Wartner, Heidrun Schaller, Sina Riemschneider, Jörg Lehmann Jörg Lehmann: AhR-Induced Anti-Inflammatory Effects on a Caco-2/THP-1 Co-Culture Model of Intestinal Inflammation Are Mediated by PPARγ. In: International Journal of Molecular Sciences, 25, 2024,